ENE. N. Nikolaeva

E. N. Nikolaeva

*This is an algorithmically generated author record based on publicly available information.

E. N. Nikolaeva has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Radiation therapy in the hypofractionation mode on the Halcyon elite linear accelerator: the first experience of St. Petersburg city clinical oncology dispensary

    by E. N. Nikolaeva, E. I. Filatova, A. A. Makulova, R. V. Orlova

    Stereotactic radiation therapy in the hypofractionation mode is a method in which high doses of ionizing radiation (more than 3 Gy per fraction) are delivered in a small number of fractions (from 2 to 5). Treatment and the process of preparation for it are carried out using special fixing devices, dosimetric planning techniques of high conformity, with control of the treatment position using x-ray imaging. which makes it possible to ensure the required irradiation accuracy. The advantages are a shorter course of treatment compared to standard fractionation, a high biologically effective dose, a reduced effect of tumor repopulation, greater efficiency under hypoxic conditions, and satisfactory results when irradiating radioresistant tumors. The article presents clinical cases of the use of hypofractionation modes on the Halcyon elite linear accelerator.

  • Open Access

    Experience in correcting skin radiation reactions with basic care products. Clinical observation

    by A. R. Akhtemzyanov, S. M. Pinyaeva, E. N. Nikolaeva, Т. Э. Эмильева

    Radiation therapy (RT) is one of the main methods of treatment of malignant tumors. More than 70% of patients with malignant tumors of various localizations require RT as part of their combination treatment. Cutaneous reactions can occur in up to 95% of patients during or after their treatment. Clinically, cutaneous radiation reactions are manifested by hyperemia, edema, burning and itching of the skin, which cause significant discomfort to patients and reduce their quality of life, especially if these processes are localized on the exposed parts of the body. Also in some localizations of malignant tumors together with RT are used antitumor drugs, which, in turn, increases the frequency of skin toxicity and worsens the clinical picture. Timely detection of the above symptoms, their adequate comprehensive therapy with the use of basic skin care products can significantly reduce or eliminate their manifestations. This article presents the clinical experience of using La Roche-Posay products during radiotherapy and chemoradiotherapy (the patients gave their informed consent for the publication of the clinical observations).